Company Winston Pharmaceuticals, Inc. Other OTC
Equities
WPHM
US9756571074
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2008 | Weight | 2009 | Weight | Delta |
---|---|---|---|---|---|
Pain Management
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +208.17% |
Sales per region
USD in Million | 2008 | Weight | 2009 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +208.17% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 81 | 91-12-31 | |
Director of Finance/CFO | 57 | - | |
Chief Operating Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 81 | 91-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 77,408,893 | 77,408,893 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Winston Pharmaceuticals, Inc.
100 North Fairway Drive Suite 134
60061-8101, Vernon Hills
+
http://www.winstonlabs.com/Sector
1st Jan change | Capi. | |
---|---|---|
+34.00% | 704B | |
+29.29% | 577B | |
-7.75% | 348B | |
+18.53% | 327B | |
+4.95% | 288B | |
+13.79% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.89% | 147B |